References

UKHSA. Tuberculosis (TB): diagnosis, screening, management and data. 2023. https//tinyurl.com/382dn522 (accessed March 2024)
Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011; 378:57-72 https://doi.org/10.1016/S0140-6736(10)62173-3
Mbuh TP, Ane-Anyangwe I, Adeline W Bacteriologically confirmed extra pulmonary tuberculosis and treatment outcome of patients consulted and treated under program conditions in the littoral region of Cameroon. BMC Pulm Med. 2019; 19 https://doi.org/10.1186/s12890-018-0770-x
WHO. Tuberculosis. 2021. https//tinyurl.com/7cmsz55t (accessed March 2024)
UKHSA. Tuberculosis (TB): social and demographic characteristics of people with TB in England. 2021. https//tinyurl.com/3pda4k5b (accessed March 2024)
PHE. Tuberculosis: the green book. Chapter 32. 2013. https//tinyurl.com/d99prhsy (accessed March 2024)
Sierra C, Fortún J, Barros C Extra-laryngeal head and neck tuberculosis. Clin Microbiol Infect. 2000; 6:644-648
Weir MR, Thornton GF. Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature. Am J Med. 1985; 79:467-78
Eng HL, Lu SY, Yang CH, Chen WJ. Oral tuberculosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996; 81:415-420
Kapoor S, Singh I, Gandhi S, Gandhi N. Oral manifestations of tuberculosis. CHRISMED J Health Res. 2014; 1 https://doi.org/10.4103/2348-3334.126772
Jain P, Jain I. Oral manifestations of tuberculosis: step towards early diagnosis. J Clin Diagn Res. 2014; 8:ZE18-21
Iype EM, Ramdas K, Pandey M Primary tuberculosis of the tongue: report of three cases. Br J Oral Maxillofac Surg. 2001; 39:402-403 https://doi.org/10.1054/bjom.2000.0663
Pekiner FN, Erseven G, Borahan MO, Gümrü B. Natural barrier in primary tuberculosis inoculation: oral mucous membrane. Int J Tuberc Lung Dis. 2006; 10
Mignogna MD, Muzio LL, Favia G Oral tuberculosis: a clinical evaluation of 42 cases. Oral Dis. 2000; 6:25-30 https://doi.org/10.1111/j.1601-0825.2000.tb00317.x
Thilander H, Wennstrom A. Tuberculosis of the mouth and the surrounding tissues. Oral Surg Oral Med Oral Pathol. 1956; 9:858-870 https://doi.org/10.1016/0030-4220(56)90353-x
Gupta N, Nuwal P, Gupta ML Primary tuberculosis of soft palate. Indian J Chest Dis Allied Sci. 2001; 43:119-121
Memon GA, Khushk IA. Primary tuberculosis of tongue. J Coll Physicians Surg Pak. 2003; 13:604-605 https://doi.org/10.2003/JCPSP.604605
Chaudhary S, Kalra N, Gomber S. Tuberculous osteomyelitis of the mandible: a case report in a 4-year-old child. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; 97:603-606
British National Formulary. 2018. https//tinyurl.com/bdhmx3tk (accessed March 2024)
Sierra C, Fortún J, Barros C Extra-laryngeal head and neck tuberculosis. Clin Microbiol Infect. 2000; 6:644-648 https://doi.org/10.1046/j.1469-0691.2000.00177.x
NICE. Tuberculosis. NICE guideline 33. 2024. http//www.nice.org.uk/guidance/ng33 (accessed March 2024)
Moonan PK, Quitugua TN, Pogoda JM Does directly observed therapy (DOT) reduce drug resistant tuberculosis?. BMC Public Health. 2011; 11 https://doi.org/10.1186/1471-2458-11-19
Hirpa S, Medhin G, Girma B Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. BMC Public Health. 2013; 13 https://doi.org/10.1186/1471-2458-13-782
Karumbi J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2015; 2015:(5) https://doi.org/10.1002/14651858.CD003343.pub4
WHO. Global tuberculosis report 2015. https//iris.who.int/handle/10665/191102 (accessed March 2024)
Jang JG, Chung JH. Diagnosis and treatment of multidrug-resistant tuberculosis. Yeungnam Univ J Med. 2020; 37:277-285 https://doi.org/10.12701/yujm.2020.00626
WHO. Report of the Guideline Development Group meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis: a review of available evidence. 2016. https//tinyurl.com/ys2jesfp (accessed March 2024)
Jensen PA, Lambert LA, Iademarco MF, Ridzon R Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005; 54:1-141
Department of Health. Health technical memorandum 01–05: decontamination in primary care dental practices. 2024. https//tinyurl.com/53kvkrm6 (accessed March 2024)
Jackson T, Thomas J. Tuberculosis: the implications for anaesthesia. S Afr J Anaesth Analg. 2013; 19:301-305 https://doi.org/10.1080/22201173.2013.10872945
Denny N, Raghunath S, Bhatia P, Abdelaziz M. Rifampicin-induced adrenal crisis in a patient with tuberculosis: a therapeutic challenge. BMJ Case Rep. 2016; 2016

Tuberculosis: Implications for Dentistry

From Volume 51, Issue 4, April 2024 | Pages 258-262

Authors

Xue-Mei Chong

BDS (Hons)

General Dental Practitioner, Liverpool

Articles by Xue-Mei Chong

Email Xue-Mei Chong

Lucy McClean

BDS (Newcastle), MFDSRCSEd, Dip Con Sed (Newcastle), MPaedDent RCSEng, FDS (Paed Dent) RCS Eng

Consultant in Paediatric Dentistry, University Dental Hospital of Manchester

Articles by Lucy McClean

Paddy McMaster

MRCP

Consultant in Paediatric Infectious Diseases, North Manchester General Hospital

Articles by Paddy McMaster

Abstract

Tuberculosis (TB) is an airborne infection caused by Mycobacterium tuberculosis complex and is highly infectious. Therefore, precautionary measures should be implemented prior to dental treatment to reduce the risk of infection to staff and other patients. Dental history and examination have a role in identification of TB infection. Complex medical history poses a challenge to safe patient management in a dental setting, and close liaison between different disciplines in managing these patients is of paramount importance. This article explores the classical clinical features of pulmonary TB, its oral manifestations and the dental management of patients with active and latent TB.

CPD/Clinical Relevance: Clinicians should be aware of the clinical features and dental management of patients with active and latent TB.

Article

Tuberculosis (TB) is an airborne infection caused by Mycobacterium tuberculosis complex and can be described as active or latent.1Mycobacterium tuberculosis mainly affects the lungs, making pulmonary TB the most common presentation. Pulmonary TB is described as TB that affects the lung parenchyma and tracheobronchial tree.2 Although Mycobacterium tuberculosis is primarily a pulmonary pathogen, it also affects other organ systems such as the gastrointestinal, lymphoreticular, musculoskeletal and reproductive systems, as well as the skin.3

Globally, 1.5 million people died from TB in 2020, with TB being the 13th leading cause of death, and one of the leading infectious killers.4 The UK is a low incidence country, but higher rates are found in larger urban areas and are highest in people born outside the UK and in deprived populations, particularly in people with a history of imprisonment, drug and alcohol misuse, homelessness and asylum seekers. TB incidence in England was 7.8 per 100,000, which is below the World Health Organization (WHO) threshold for a low incidence country (less than or equal to 10 per 100,000 population).5 Data from the UK Health Security Agency (UKHSA) reveals that the number of notifications increased by 7% in the first half of 2023 compared with the first half of 2022. TB notification rates varied widely across the country, with the highest in London and the lowest in the north-east. Despite an overall downward trend in the number and rate of TB notifications in England over the past 10 years, the rate of decline is slowing.

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available